|
|
Volumn 62, Issue 10, 2007, Pages 662-663
|
|
A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata: Commentary
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASOPRISNIL;
BISPHOSPHONIC ACID DERIVATIVE;
ESTROGEN;
GESTAGEN;
GONADORELIN DERIVATIVE;
GONADOTROPIN;
HEMOGLOBIN;
HORMONE RECEPTOR STIMULATING AGENT;
MIFEPRISTONE;
PLACEBO;
ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD;
AFRICAN AMERICAN;
AMENORRHEA;
BLOATING;
BLOOD CHEMISTRY;
BLOOD PRESSURE;
CANADA;
CAUCASIAN;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG TOLERABILITY;
DYSPAREUNIA;
ECHOGRAPHY;
ENDOMETRIUM;
ESTROGEN BLOOD LEVEL;
GONADOTROPIN BLOOD LEVEL;
GROUPS BY AGE;
HUMAN;
HYPERPLASIA;
HYSTERECTOMY;
INTRAUTERINE PRESSURE;
LOW DRUG DOSE;
MENSTRUATION;
NOTE;
OSTEOLYSIS;
PATIENT MONITORING;
PELVIC DISEASE;
PELVIS PAIN SYNDROME;
SPOTTING;
STATISTICAL SIGNIFICANCE;
TREATMENT DURATION;
TREATMENT RESPONSE;
TUMOR VOLUME;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
UTERINE CERVIX DISEASE;
UTERUS BLEEDING;
UTERUS MYOMA;
|
|
EID: 34848867295
PISSN: 00297828
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ogx.0000282008.71463.a2 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|